ANOUSH YAMINIFAR: Open Payments
NPI 1407305766 · CHICO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,185 in 50 payments from 19 companies in 2025. Trend: 2023 $342 · 2024 $907 · 2025 $1,185
Food & beverage: $1,185
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 4 | $181 |
| Novo Nordisk Inc | 8 | $174 |
| Daiichi Sankyo Inc. | 4 | $170 |
| ABBVIE INC. | 11 | $152 |
| AstraZeneca Pharmaceuticals LP | 1 | $107 |
| Dexcom, Inc. | 3 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $48 |
| Janssen Pharmaceuticals, Inc | 2 | $37 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| Lilly USA, LLC | 2 | $31 |
Products named: Auvelity, INJECTAFER, TEZSPIRE, UBRELVY, Wegovy, Rybelsus, Dexcom G6 Transmitter, QULIPTA.
Industry payments across CA — which companies pay providers there.
